These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 35108311)

  • 1. Comparing the impact of vaccination strategies on the spread of COVID-19, including a novel household-targeted vaccination strategy.
    Voigt A; Omholt S; Almaas E
    PLoS One; 2022; 17(2):e0263155. PubMed ID: 35108311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modelling direct and herd protection effects of vaccination against the SARS-CoV-2 Delta variant in Australia.
    McBryde ES; Meehan MT; Caldwell JM; Adekunle AI; Ogunlade ST; Kuddus MA; Ragonnet R; Jayasundara P; Trauer JM; Cope RC
    Med J Aust; 2021 Nov; 215(9):427-432. PubMed ID: 34477236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modelling of COVID-19 vaccination strategies and herd immunity, in scenarios of limited and full vaccine supply in NSW, Australia.
    MacIntyre CR; Costantino V; Trent M
    Vaccine; 2022 Apr; 40(17):2506-2513. PubMed ID: 33958223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.
    Chaudhary JK; Yadav R; Chaudhary PK; Maurya A; Kant N; Rugaie OA; Haokip HR; Yadav D; Roshan R; Prasad R; Chatrath A; Singh D; Jain N; Dhamija P
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contact-adjusted Immunity Levels against SARS-CoV-2 in Korea and Prospects for Achieving Herd Immunity.
    Chun JY; Jeong H; Kim Y
    J Korean Med Sci; 2021 Oct; 36(38):e272. PubMed ID: 34609093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 vaccines and herd immunity: Perspectives, challenges and prospects.
    Wong RSY
    Malays J Pathol; 2021 Aug; 43(2):203-217. PubMed ID: 34448786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Model based estimation of the SARS-CoV-2 immunization level in austria and consequences for herd immunity effects.
    Bicher M; Rippinger C; Schneckenreither G; Weibrecht N; Urach C; Zechmeister M; Brunmeir D; Huf W; Popper N
    Sci Rep; 2022 Feb; 12(1):2872. PubMed ID: 35190590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The herd-immunity threshold must be updated for multi-vaccine strategies and multiple variants.
    Yadegari I; Omidi M; Smith SR
    Sci Rep; 2021 Nov; 11(1):22970. PubMed ID: 34836984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Five reasons why COVID herd immunity is probably impossible.
    Aschwanden C
    Nature; 2021 Mar; 591(7851):520-522. PubMed ID: 33737753
    [No Abstract]   [Full Text] [Related]  

  • 10. Herd immunization with childhood vaccination may provide protection against COVID-19.
    Yu Y
    Acta Microbiol Immunol Hung; 2020 Sep; 67(3):198-200. PubMed ID: 32986604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 vaccines: A critical perspective through efficacy data and barriers to herd immunity.
    Blasi F; Gramegna A; Sotgiu G; Saderi L; Voza A; Aliberti S; Amati F
    Respir Med; 2021; 180():106355. PubMed ID: 33721697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SIRS epidemics with individual heterogeneity of immunity waning.
    El Khalifi M; Britton T
    J Theor Biol; 2024 Jun; 587():111815. PubMed ID: 38614211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Herd immunity: challenges and the way forward in Korea.
    Oh J; Kim S; Ryu B; Shin M; Kim BI
    Epidemiol Health; 2021; 43():e2021054. PubMed ID: 34412446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "Hot-spotting" to improve vaccine allocation by harnessing digital contact tracing technology: An application of percolation theory.
    Penney MD; Yargic Y; Smolin L; Thommes EW; Anand M; Bauch CT
    PLoS One; 2021; 16(9):e0256889. PubMed ID: 34551000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of vaccination on the COVID-19 pandemic in U.S. states.
    Chen X; Huang H; Ju J; Sun R; Zhang J
    Sci Rep; 2022 Jan; 12(1):1554. PubMed ID: 35091640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are COVID vaccination programmes working? Scientists seek first clues.
    Mallapaty S
    Nature; 2021 Jan; 589(7843):504-505. PubMed ID: 33483685
    [No Abstract]   [Full Text] [Related]  

  • 17. Return to normal pre-COVID-19 life is delayed by inequitable vaccine allocation and SARS-CoV-2 variants.
    Liu F; Zhao Z; Ma C; Nie X; Wu A; Li X
    Epidemiol Infect; 2022 Jan; 150():e46. PubMed ID: 35067231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Network models to evaluate vaccine strategies towards herd immunity in COVID-19.
    Tetteh JNA; Nguyen VK; Hernandez-Vargas EA
    J Theor Biol; 2021 Dec; 531():110894. PubMed ID: 34508758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Who should be prioritised for COVID-19 vaccination?
    Russell FM; Greenwood B
    Hum Vaccin Immunother; 2021 May; 17(5):1317-1321. PubMed ID: 33141000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Long Road Toward COVID-19 Herd Immunity: Vaccine Platform Technologies and Mass Immunization Strategies.
    Frederiksen LSF; Zhang Y; Foged C; Thakur A
    Front Immunol; 2020; 11():1817. PubMed ID: 32793245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.